221 related articles for article (PubMed ID: 29880898)
1. Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines.
Zhou QH; Deng CZ; Li ZS; Chen JP; Yao K; Huang KB; Liu TY; Liu ZW; Qin ZK; Zhou FJ; Huang W; Han H; Liu RY
Cell Death Dis; 2018 Jun; 9(6):684. PubMed ID: 29880898
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review.
Ribera-Cortada I; Guerrero-Pineda J; Trias I; Veloza L; Garcia A; Marimon L; Diaz-Mercedes S; Alamo JR; Rodrigo-Calvo MT; Vega N; López Del Campo R; Parra-Medina R; Ajami T; Martínez A; Reig O; Ribal MJ; Corral-Molina JM; Jares P; Ordi J; Rakislova N
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008677
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
[TBL] [Abstract][Full Text] [Related]
4. Establishment and Characterization of Advanced Penile Cancer Patient-derived Tumor Xenografts: Paving the Way for Personalized Treatments.
Elst L; Van Rompuy AS; Roussel E; Spans L; Vanden Bempt I; Necchi A; Ross J; Jacob JM; Baietti MF; Leucci E; Albersen M
Eur Urol Focus; 2022 Nov; 8(6):1787-1794. PubMed ID: 35537937
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis.
Chen J; Yao K; Li Z; Deng C; Wang L; Yu X; Liang P; Xie Q; Chen P; Qin Z; Ye Y; Liu Z; Zhou F; Zhang Z; Han H
Oncotarget; 2016 Aug; 7(32):51687-51698. PubMed ID: 27351128
[TBL] [Abstract][Full Text] [Related]
6. Molecular stratification by BCL2A1 and AIM2 provides additional prognostic value in penile squamous cell carcinoma.
Tan X; Chen D; Guo S; Wang Y; Zou Y; Wu Z; Zhou F; Qin Z; Liu Z; Cao Y; Lin C; Yuan G; Yao K
Theranostics; 2021; 11(3):1364-1376. PubMed ID: 33391539
[No Abstract] [Full Text] [Related]
7. EGFR mono-antibody salvage therapy for locally advanced and distant metastatic penile cancer: Clinical outcomes and genetic analysis.
Huang KB; Liu RY; Peng QH; Li ZS; Jiang LJ; Guo SJ; Zhou QH; Liu TY; Deng CZ; Yao K; Qin ZK; Liu ZW; Li YH; Han H; Zhou FJ
Urol Oncol; 2019 Jan; 37(1):71-77. PubMed ID: 30446465
[TBL] [Abstract][Full Text] [Related]
8. Molecular and genomic characterisation of a panel of human anal cancer cell lines.
Guerra GR; Kong JC; Millen RM; Read M; Liu DS; Roth S; Sampurno S; Sia J; Bernardi MP; Chittleborough TJ; Behrenbruch CC; Teh J; Xu H; Haynes NM; Yu J; Lupat R; Hawkes D; Di Costanzo N; Tothill RW; Mitchell C; Ngan SY; Heriot AG; Ramsay RG; Phillips WA
Cell Death Dis; 2021 Oct; 12(11):959. PubMed ID: 34663790
[TBL] [Abstract][Full Text] [Related]
9. PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer.
Adimonye A; Stankiewicz E; La-Touche S; Kudahetti S; Trevisan G; Tinwell B; Corbishley C; Lu YJ; Watkin N; Berney D
PLoS One; 2018; 13(6):e0198905. PubMed ID: 29902261
[TBL] [Abstract][Full Text] [Related]
10. Mutational landscape of penile squamous cell carcinoma in a Chinese population.
Wang Y; Wang K; Chen Y; Zhou J; Liang Y; Yang X; Li X; Cao Y; Wang D; Luo L; Li B; Li D; Wang L; Liang Z; Gao C; Wang Q; Lv Q; Li Z; Shi Y; Niu H
Int J Cancer; 2019 Sep; 145(5):1280-1289. PubMed ID: 31034097
[TBL] [Abstract][Full Text] [Related]
11. The role of Her-2 in penile squamous cell carcinoma progression and cisplatin chemoresistance and potential for antibody-drug conjugate-based therapy.
Tan X; Wang Y; Wu Z; Zhou Q; Tang Y; Liu Z; Yuan G; Luo S; Zou Y; Guo S; Han N; Yao K
Eur J Cancer; 2023 Nov; 194():113360. PubMed ID: 37862796
[TBL] [Abstract][Full Text] [Related]
12. Genetics and penile cancer: recent developments and implications.
Chahoud J; Pickering CR; Pettaway CA
Curr Opin Urol; 2019 Jul; 29(4):364-370. PubMed ID: 31045928
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma.
Chahoud J; Gleber-Netto FO; McCormick BZ; Rao P; Lu X; Guo M; Morgan MB; Chu RA; Martinez-Ferrer M; Eterovic AK; Pickering CR; Pettaway CA
Clin Cancer Res; 2021 May; 27(9):2560-2570. PubMed ID: 33441293
[TBL] [Abstract][Full Text] [Related]
14. Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy.
McDaniel AS; Hovelson DH; Cani AK; Liu CJ; Zhai Y; Zhang Y; Weizer AZ; Mehra R; Feng FY; Alva AS; Morgan TM; Montgomery JS; Siddiqui J; Sadis S; Bandla S; Williams PD; Cho KR; Rhodes DR; Tomlins SA
Cancer Res; 2015 Dec; 75(24):5219-27. PubMed ID: 26670561
[TBL] [Abstract][Full Text] [Related]
15. Understanding genomics and the immune environment of penile cancer to improve therapy.
Aydin AM; Chahoud J; Adashek JJ; Azizi M; Magliocco A; Ross JS; Necchi A; Spiess PE
Nat Rev Urol; 2020 Oct; 17(10):555-570. PubMed ID: 32812000
[TBL] [Abstract][Full Text] [Related]
16. Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.
Jacob JM; Ferry EK; Gay LM; Elvin JA; Vergilio JA; Ramkissoon S; Severson E; Necchi A; Killian JK; Ali SM; Schrock AB; Liu NW; Chung J; Miller VA; Stephens PJ; Welsh A; Corona RJ; Ross JS; Bratslavsky G
J Urol; 2019 Mar; 201(3):541-548. PubMed ID: 30291913
[TBL] [Abstract][Full Text] [Related]
17. Mutational Signature and Integrative Genomic Analysis of Human Papillomavirus-Associated Penile Squamous Cell Carcinomas from Latin American Patients.
Canto LM; da Silva JM; Castelo-Branco PV; da Silva IM; Nogueira L; Fonseca-Alves CE; Khayat A; Birbrair A; Pereira SR
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884575
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ID1 promotes tumor progression in penile squamous cell carcinoma.
Hu X; Chen M; Li Y; Wang Y; Wen S; Jun F
Oncol Rep; 2019 Feb; 41(2):1091-1100. PubMed ID: 30535485
[TBL] [Abstract][Full Text] [Related]
19. Immune landscape and immunotherapy for penile cancer.
Tang Y; Hu X; Wu K; Li X
Front Immunol; 2022; 13():1055235. PubMed ID: 36524123
[TBL] [Abstract][Full Text] [Related]
20. HPV-associated penile cancer: Impact of copy number alterations in miRNA/mRNA interactions and potential druggable targets.
Silva JD; Nogueira L; Coelho R; Deus A; Khayat A; Marchi R; Oliveira E; Santos APD; Cavalli L; Pereira S
Cancer Biomark; 2021; 32(2):147-160. PubMed ID: 34151841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
